Caribou Biosciences: Syed Rizvi
Syed Rizvi has been appointed as chief medical officer of Caribou Biosciences, a new position at the company. Most recently, he served in the same role at Chimeric Therapeutics, and before that, he held various roles, including head and VP of clinical development, at Legend Biotech. Previously, he was head of global medical affairs for CAR-T cell programs and head of hematology and immuno-oncology for US medical affairs at Celgene. Rizvi holds a medical degree from Dow Medical College.